Prices checked · 1 Sweden-based vendor · No affiliate links
1 Sweden-based vendor currently list Orforglipron, with 1 in-stock listings. The median price is — per mg. Compare all 5 vendors worldwide.
1 vendor · 1 listing
Weekly price tracking for Orforglipron started 18 November 2026. The trend chart appears after three weekly checks.
No vendor here is PeptideTrace Verified yet — Verified means a third-party Certificate of Analysis passed our published checks. How verification works.
1 of 1 vendors state on their own sites that they third-party test (vendor claims, not checked by PeptideTrace):
Investigational · Oral Non-Peptide GLP-1 Agonist
Orforglipron is in Phase III development (not yet approved). Phase II results (272 patients, 36 weeks) showed up to 14.7% weight loss. Phase III results (ATTAIN-1, 3,127 patients, 72 weeks) showed 11–12% weight loss, which is less than injectable GLP-1 agonists but achieved with a once-daily pill. Orforglipron is not a peptide. Its significance is in potentially making GLP-1-based obesity treatment available in pill form without the cold-chain storage and injection requirements of current peptide-based treatments. Phase III trials for type 2 diabetes are also ongoing.
Molecular weight: 883.00 Da — a mass spectrometry result on a COA should match this.
Full Orforglipron profile: research, trials and regulation →1 Sweden-based vendor currently list Orforglipron (1 in-stock listings). The full list with prices is above. PeptideTrace does not sell Orforglipron and earns no commission.
The median price is — per mg (middle half of listings: —–— per mg). The lowest in-stock listing is —. Prices checked 18 November 2026.
None of these vendors is PeptideTrace Verified yet. 1 of 1 state on their sites that they third-party test — vendor claims, not checked by PeptideTrace.
How this page works: PeptideTrace checks every tracked vendor's public shop weekly and records price, size and stock for each listing. Per-mg figures use listings priced in SEK. Kits are counted by total mg; wholesale, oral and bundle listings are excluded from per-mg comparisons. Last checked 18 November 2026. Methodology. PeptideTrace uses no affiliate links and earns no commission.
This compound is currently in clinical trials and is not yet approved for commercial sale. Information is for research reference only.